AGIO Exercise Disclosure
Gheuens Sarah · SEC Form 4 · Filed Oct 28, 2026
Exercise
Calculated transaction value
$0
Gheuens Sarah Chief Medical Officer
AGIO
Transaction date
Oct 26, 2026
Public filing date
Oct 28, 2026
Filing lag
Filed 2 days later
AGIO daily price context
Close on/before transaction
$36.85
Oct 26, 2026
First close after public filing
--
Unavailable
30-day return after filing
--
Through Unavailable
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Stock options (right to buy) on Common stock
- Quantity / price
- 7,866 shares @ $0
- SEC ownership
- Direct
- Transaction code
- M
- Form
- 4
- Filing identifier
- 0001439222-26-000124
Filing cohort
Transactions in this filing
Showing 3 of 3
Trades
3
Issuers
1
Estimated value
$493.2K
Buys / sales
0 / 1
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Agios Pharmaceuticals, Inc. AGIO Current | Exercise | Oct 26, 2026 | $0 |
| Agios Pharmaceuticals, Inc. AGIO | Exercise | Oct 26, 2026 | $196.73K |
| Agios Pharmaceuticals, Inc. AGIO | Sale | Oct 26, 2026 | $296.47K |